Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?

Annals of Oncology

Volumn 25, Issue 5, 2014, Pages 921-927

  Adams, H J A ^a   Kwee, T C ^a   de Keizer, B ^a   Fijnheer, R ^b   de Klerk, J M H ^c   Littooij, A S ^a   Nievelstein, R A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Departments of Hematology

^c MEANDER MEDICAL CENTER   (Netherlands)

Author keywords

biopsy; bone marrow; FDG PET CT; Hodgkin; meta analysis; systematic review

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

BIOPSY; BONE MARROW; BONE MARROW CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; HODGKIN DISEASE; HUMAN; META ANALYSIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING; SECONDARY;

BIOPSY; BONE MARROW; BONE MARROW NEOPLASMS; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84907858609     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt533     Document Type: Review

References (31)

1. Eichenauer, D.A., Engert, A., Dreyling, M., Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22:Suppl 6 (2011), vi55–vi58.
2. Connors, J.M., State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol 23 (2005), 6400–6408.
3. Bain, B.J., Bone marrow biopsy morbidity and mortality: 2002 data. Clin Lab Haematol 26 (2004), 315–318.
4. Kwee, T.C., de Klerk, J.M., Nievelstein, R.A., Imaging of bone marrow involvement in lymphoma: state of the art and future directions. ScientificWorldJournal 11 (2011), 391–402.
5. Hutchings, M., Loft, A., Hansen, M., et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91 (2006), 482–489.
6. Weiler-Sagie, M., Bushelev, O., Epelbaum, R., et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51 (2010), 25–30.
7. Vassilakopoulos, T.P., Angelopoulou, M.K., Constantinou, N., et al. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood 105 (2005), 1875–1880.
8. Whiting, P.F., Rutjes, A.W., Westwood, M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155 (2011), 529–536.
9. Brunning, R.D., Bloomfield, C.D., McKenna, R.W., et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 82 (1975), 365–366.
10. Coller, B.S., Chabner, B.A., Gralnick, H.R., Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol 3 (1977), 105–119.
11. Haddy, T.B., Parker, R.I., Magrath, I.T., Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 17 (1989), 418–423.
12. Wang, J., Weiss, L.M., Chang, K.L., et al. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 94 (2002), 1522–1531.
13. Deville, W.L., Buntinx, F., Bouter, L.M., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol, 2, 2002, 9.
14. Moses, L.E., Shapiro, D., Littenberg, B., Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12 (1993), 1293–1316.
15. Higgins, J.P., Thompson, S.G., Deeks, J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
16. Glas, A.S., Lijmer, J.G., Prins, M.H., et al. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56 (2003), 1129–1135.
17. 18F-FDG PET/CT versus bone marrow biopsy. Clin Nucl Med, 2013 DOI:10.1097/RLU.0b013e31828e9504.
18. Agrawal, K., Mittal, B.R., Bansal, D., et al. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma. Ann Nucl Med 27 (2013), 146–151.
19. 18F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma. Br J Radiol 85 (2012), e490–e496.
20. El-Galaly, T.C., d'Amore, F., Mylam, K.J., et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol 30 (2012), 4508–4514.
21. Pelosi, E., Penna, D., Douroukas, A., et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study. Q J Nucl Med Mol Imaging 55 (2011), 469–475.
22. Mittal, B.R., Manohar, K., Malhotra, P., et al. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?. Leuk Lymphoma 52 (2011), 2111–2116.
23. Cheng, G., Chen, W., Chamroonrat, W., et al. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 38 (2011), 1469–1476.
24. Moulin-Romsee, G., Hindie, E., Cuenca, X., et al. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 37 (2010), 1095–1105.
25. Ngeow, J.Y., Quek, R.H., Ng, D.C., et al. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma. Ann Oncol 20 (2009), 1543–1547.
26. Lister, T.A., Crowther, D., Sutcliffe, S.B., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7 (1989), 1630–1636.
27. 18F-fluoro-2-deoxyglucose positron emission tomography era. Leuk Lymphoma 53 (2012), 381–385.
28. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 46 (2005), 958–963.
29. Levis, A., Pietrasanta, D., Godio, L., et al. A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. Clin Lymphoma 5 (2004), 50–55.
30. Howell, S.J., Grey, M., Chang, J., et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 119 (2002), 408–411.
31. 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?. Eur J Nucl Med Mol Imaging 36 (2009), 1813–1821.